Results 71 to 80 of about 3,130,322 (229)

Robotic Surgery Versus Conventional Laparoscopy and Laparotomy for Ovarian Cancer: A Systematic Review and Meta-analysis [PDF]

Journal of Kerman University of Medical Sciences
Background: This research aimed to evaluate differences in overall survival, recurrence frequency, and both intraoperative and postoperative results in ovarian cancer (OC) patients treated with robotic surgery, laparoscopic procedures, or open laparotomy.
Seyedeh Azam Pourhoseini, Leili Hafizi, Shadi Moloughi, Amin Dalili   +3 more
doaj   +1 more source

Splenectomy as an indicator for ovarian cancer spread and complete cytoreduction.

Gynecologic Oncology
OBJECTIVE Complete cytoreductive surgery (CRS) is a gold standard in advanced ovarian cancer (OC) treatment, and most of the time, requires upper abdominal procedures.
E. Karlsson, Oksana Vorobii, I. Silins, I. Sundström Poromaa, K. Stålberg, M. Lomnytska   +5 more
semanticscholar   +1 more source

Rare Feline Gingival Extramedullary Plasmacytoma: Clinical Application of Electrochemotherapy for Local Control

Veterinary Medicine and Science, Volume 12, Issue 6, November 2026.
This case report describes an aggressive gingival extramedullary plasmacytoma (EMP) with regional lymph node metastasis in a 14‐year‐old cat. As complete surgical excision was unfeasible, three weekly electrochemotherapy (ECT) sessions using intravenous bleomycin were performed for local tumour control.
Seulgi Hwang, Hayoung Ryu, Dong‐In Jung, DoHyeon Yu, Kyu‐Woan Cho, Hyeona Bae   +5 more
wiley   +1 more source

Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study

, 2009
To assess feasibility, complications and efficacy of secondary surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in a selected group of platinum-sensitive recurrent ovarian cancer ...
A. Fagotti, A. Naldini, Grimolizzi, Filomena, Scambia, Giovanni, G. Vizzielli, I. Paris, Fagotti, Anna, Paris, Ida, F. Grimolizzi, G. Scambia, Fanfani, F, F. Fanfani, Paris I., Scambia G., Scambia, G., Fagotti A., Vizzielli, G., FANFANI, Francesco, Grimolizzi, F., Grimolizzi F., Naldini, A., Fagotti, A., Naldini A., Paris, I., Vizzielli G., Fanfani F.   +25 more
core   +1 more source

Surgical complexity impact on survival after complete cytoreductive surgery for Advanced ovarian cancer [PDF]

, 2016
INTRODUCTION: The direct relationship between surgical radicality to compensate biologic behavior and improvement of patient outcome at the time of primary or interval cytoreduction remains unclear.
Filleron, Thomas, Querleu, Denis, Luyckx, M., Guyon, F., Classe, Jean-Marc, Martinez, A., Gouy, Sébastien, Ngo, C., Pomel, Christophe, Gouy, S., Darai, E., Ferron, G., Guyon, Frédéric, Daraı̈, Émile, Classe, J., M, Pomel, C., Leblanc, E., Filleron, T., Ngô, Charlotte, Luyckx, Mathieu, Leblanc, Éric, Querleu, D., Ferron, Gwénaël, Martínez, Alejandra   +23 more
core   +1 more source

Transaortic removal of a large primary sarcoma from the left ventricle assisted by strategic partial resection and endoscopic guidance: a case report

Journal of Cardiothoracic Surgery
Background Surgical resection remains the mainstay of treatment for cardiac sarcoma, a rare but lethal disease. Achieving complete removal of a large-sized left ventricular sarcoma remains a challenge even with various surgical approaches that have been ...
Jae-Sung Choi, Jeongwon Kim, Se Jin Oh, You Jung Ok, Yong Won Seong, Hyeon Jong Moon   +5 more
doaj   +1 more source

Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany

BMJ Open, 2020
Introduction Objective of the ‘German hyperthermic intrathoracic chemotherapy (HITOC) study’ is to evaluate the HITOC as additional treatment after surgical cytoreduction for malignant pleural tumours.
Gunnar Huppertz, Hauke Winter, Rudolf Hatz, Till Markowiak, Florian Zeman, Hans-Stefan Hofmann, Michael Ried, Martin Eichhorn, Laura Klotz, Julia Zimmermann, Julia Kovacs, Bernward Passlick, Severin Schmid, Mohamed Hassan   +13 more
doaj   +1 more source

Spectral CT in peritoneal carcinomatosis from ovarian cancer: a tool for differential diagnosis of small nodules?

European Radiology Experimental, 2022
The detection of peritoneal carcinomatosis in patients with ovarian cancer is crucial to establish the correct therapeutic planning (debulking surgery versus neoadjuvant chemotherapy).
Giada Zorzetto, Andrea Coppola, Valeria Molinelli, Maria Gloria Angeretti, Jvan Casarin, Federico Fontana, Filippo Piacentino, Giulio Carcano, Fabio Ghezzi, Massimo Venturini   +9 more
doaj   +1 more source

Robotic Secondary Cytoreduction with 3D Reconstruction for Isolated Recurrent Ovarian Cancer: A Stepwise Approach to Splenectomy

Annals of Surgical Oncology
Isolated parenchymal splenic relapse is a rare condition experienced by patients presenting with recurrent ovarian cancer (ROC).1–3, 2 In such cases, complete secondary cytoreductive surgery (SCS) followed by chemotherapy offers significant overall ...
R. Oliva, A. Rosati, C. Certelli, Luca Palmieri, M. T. Giudice, G. Scaglione, J. Marescaux, G. Scambia, A. Fagotti, V. Gallotta   +9 more
semanticscholar   +1 more source

Histone deacetylase inhibitors as venetoclax‐sensitising partners in acute myeloid leukaemia: Mechanisms, pharmacology and translational perspectives

British Journal of Pharmacology, Volume 183, Issue 21, Page 6261-6290, November 2026.
Abstract Venetoclax combined with hypomethylating agents has improved treatment for older or unfit patients with acute myeloid leukaemia (AML), but resistance and relapse remain common. This review analyses the rationale for combining venetoclax with inhibitors of histone deacetylase (HDAC).
Jaebok Lee, Marc Diederich
wiley   +1 more source